Put companies on watchlist
Linde plc
ISIN: IE00BZ12WP82
WKN: A2DSYC
More AI Integrations
About
Company Snapshot
New: Enable Investor Alerts
Be informed about new publications
New: AI Factsheet

Corporate News meets AI! 
Content analysis and summary

Linde plc · ISIN: IE00BZ12WP82 · EQS - Company News (129 News)
Country: Great Britain · Primary market: Ireland · EQS NID: 1468607
21 October 2022 11:59AM

Linde Expands Agreement with Jindal Steel in India


EQS-News: Linde plc / Key word(s): Miscellaneous
Linde Expands Agreement with Jindal Steel in India

21.10.2022 / 11:59 CET/CEST
The issuer is solely responsible for the content of this announcement.


Linde Expands Agreement with Jindal Steel in India

Woking, UK, October 21, 2022 – Linde (NYSE:LIN; FWB:LIN) today announced it has expanded its existing long-term agreement for the supply of industrial gases with Jindal Stainless Limited (JSL), one of the largest stainless steel producers in India.

Linde already supplies oxygen, nitrogen and argon to JSL from its on-site Air Separation Unit (ASU) at the Kalinganagar Industrial Estate in Odisha, East India. Under the terms of the new agreement, Linde will build a second ASU, more than tripling the current total capacity of its plant at Kalinganagar. The additional supply will support the significant expansion of JSL’s facility. The new ASU is expected to start up in the first half of 2024 and will be an additional supply source for the local merchant market.

“We are proud to develop our partnership with JSL as it embarks on a significant expansion of its stainless steel production facility at Kalinganagar,” said Moloy Banerjee, President ASEAN & South Asia, Linde. “By building additional capacity to support JSL’s growth, we will increase Linde’s own network density in one of India’s most important industrial regions.”

 

About Linde

Linde is a leading global industrial gases and engineering company with 2021 sales of $31 billion (€26 billion). We live our mission of making our world more productive every day by providing high-quality solutions, technologies and services which are making our customers more successful and helping to sustain and protect our planet.

The company serves a variety of end markets including chemicals & energy, food & beverage, electronics, healthcare, manufacturing, metals and mining. Linde's industrial gases are used in countless applications, from life-saving oxygen for hospitals to high-purity & specialty gases for electronics manufacturing, hydrogen for clean fuels and much more. Linde also delivers state-of-the-art gas processing solutions to support customer expansion, efficiency improvements and emissions reductions.

For more information about the company and its products and services, please visit www.linde.com

 
Contacts:
 
 
 
Investor Relations 
Juan Pelaez
Phone: +1 203 837 2213
Email: juan.pelaez@linde.com
 
Media Relations
Anna Davies
Phone: +44 1483 244705
Email: anna.davies@linde.com
 

 



21.10.2022 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com


Language: English
Company: Linde plc
Forge, 43 Church Street West
GU21 6HT Woking, Surrey
United Kingdom
Phone: +1-203-837-2210
E-mail: Investor_Relations@Linde.com
Internet: www.linde.com
ISIN: IE00BZ12WP82
WKN: A2DSYC
Indices: DAX
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange; Moscow, NYSE, Luxembourg Stock Exchange (Euro MTF)
EQS News ID: 1468607

 
End of News EQS News Service

1468607  21.10.2022 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1468607&application_name=news&site_id=boersengefluester_html
MIC: XNYS

This publication was provided by our content partner EQS3.

EQS Newswire
via EQS - Newsfeed
EQS Group AG ©2025
(DGAP)
Contact:
Karlstraße 47 D-80333 München
+49 (0) 89 444 430-000

P R O D U C T   S U G G E S T I O N S

The information presented here has been provided by our content partner EQS-Group. The originator of the news is the respective issuer, the company relating to the news, a publication service provider (press or information agency) which uses the distribution service of EQS to transmit company news to shareholders, investors, investors or interested parties. The original publications and other company-relevant information can be found at eqs-news.com.


The information you can access does not constitute investment advice. The presentation of our cooperation partners, where the implementation of investment decisions would be possible depending on the individual risk profile, is solely at the discretion of the person using the service. We only present companies of which we are convinced that the range of services and customer service will satisfy discerning investors.

If you are considering leverage products, familiarise yourself with the typical characteristics of the financial instruments beforehand. Take the time to determine the risk content of the planned investment before making an investment decision. Bear in mind that a total loss cannot be ruled out with leverage products.

For newcomers to the subject, we offer various options in both the training and the tools section, through which you can train theoretical knowledge and practical experience and thus improve your skills. The offer ranges from participation in webinars to personal mentoring. The range is continuously being expanded.


1 Lab features are usually functionalities that emerge from the think tank of the investor community. In the early stages, these are experimental functionalities whose development process is largely determined by use and the resulting feedback from the community. When integrating external services or functionalities, the functionality can only be guaranteed to the extent that the individual process elements, such as interfaces, interact with each other.